Asia-Pacific Conjugate Vaccine Market:
Conjugate vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached with a protein to enhance immunogenicity and protect against invasive diseases. Asia Pacific is the fastest growing market for conjugate vaccines. The conjugate vaccines market in Asia-Pacific is expected to expand at a CAGR of 23.5%, leading to a revenue of USD 66.61 Bn by 2023. By volume, it is anticipated to reach 6,883.55 Million units by 2023, expanding at a CAGR of 21.87%.
A penetration rate of around 95% of DTP conjugate vaccines indicates an excellent coverage in Asia-Pacific countries and very little is left to achieve full penetration for the vaccines. Countries with high populations such as China and India, serve as major target areas for such vaccines, and the introduction of these vaccines would ensure a disease-free society.
Market Segmentation:
By disease indication, the market is segmented into:
o Pneumococcal
o Haemophilus influenza type B
o Diphtheria-tetanus-pertussis
o Meningococcal
o Others
By end user, the market is segmented into:
o Paediatric
o Adult
By countries, the Asia-Pacific market is divided into:
o China
o India
o Japan
o South Korea
Key growth factors:
The Asia Pacific has a growing market owing to improvement and advancements in medical science. Awareness about availability of higher number of vaccines as compared to before are major driving factors for the growth of this market. The primary indicators of the potential for the vaccine market are the geriatric population in Asia and its growth in some countries such as India and China. This has encouraged market participants to increase spending on research and development, and distribution facilities in Asian countries.
Threats and key players:
o The Asia-Pacific Conjugate Vaccine market is expected to grow at a significant rate. But there are issues with regard to health care access and costs. Fragmented health care has a negative impact on the effectiveness of any proposed immunization strategy. Adolescent and adult pertussis is under-recognized by lay and medical communities due to its unique clinical presentation.
o Conjugate Vaccine providers operating in the market are GlaxoSmithKline, Pfizer Inc., Merck, Novartis, Sanofi Pasteur, etc.
What's covered in the report?
1. Overview of the Asia-Pacific conjugate vaccine market
2. Market drivers, and challenges in the Asia-Pacific conjugate vaccine market
3. Market trends in the Asia-Pacific conjugate vaccine market
4. Historical, current and forecasted market size data for the Asia-Pacific based on disease indication (pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal conjugate vaccines) - by revenue and by volume
5. Historical, current and forecasted market size data for the Asia-Pacific based on end user (paediatric and adult conjugate vaccines) - by revenue and by volume
6. Historical, current and forecasted market size data of conjugate vaccines of countries (China, India, Japan and South Korea) - by revenue and by volume
7. Historical, current and forecasted market size data for country-wise segments - by revenue and by volume
8. Analysis of the competitive landscape and profiles of major competitors operating in the Asia-Pacific market
Why buy?
o Understand the demand for conjugate vaccines to determine the viability of the market
o Understand the country-specific market size and observations for each segment
o Develop strategies based on the drivers, trends and highlights for each of the segments
o Evaluate the value chain to determine the workflow and to get an idea of the current position where you are placed
o Recognize the key competitors of this market and respond accordingly
o Identify the initiatives and growth strategies taken up by the major companies and decide on the direction of further growth
o Define the competitive positioning by comparing the products and services with the key players in the market
Customizations available
With the given market data, Netscribes offers customizations according to specific needs. Write to us at [email protected].
Asia-Pacific Conjugate Vaccine Market (2018-2023)
Table of Contents
Chapter 1: Executive summary
1.1 Market scope and segmentation
1.2 Key questions answered in this study
1.3 Executive summary - I
1.4 Executive summary - II
Chapter 2: Market overview
2.1. Market definitions
2.2. Asia-Pacific market overview - by revenue
- Asia-Pacific historical (2015-2017) market revenue (USD Bn)
- Asia-Pacific forecasted (2018-2023) market revenue (USD Bn)
- Country-wise market (2018-2023) revenue (USD Bn)
2.3. Asia-Pacific market overview - by volume
- Asia-Pacific historical (2015-2017) market volume (Million units)
- Asia-Pacific forecasted (2018-2023) market volume (Million units)
- Country-wise (2018-2023) market volume (Million units)
2.4. Asia-Pacific market drivers and challenges
2.4.1. Asia-Pacific market drivers
2.4.2. Asia-Pacific market challenges
2.5. Asia-Pacific market trends
2.6. Value chain
2.7.1. Country-specific market overview - China
- Observation
- Key competitors
2.7.1(A) Country-specific market overview - China by revenue and by volume
- China historical (2015-2017) market revenue (USD Bn)
- China forecasted (2018-2023) market revenue (USD Bn)
- China historical (2015-2017) market volume (Million units)
- China forecasted (2018-2023) market volume (Million units)
2.7.2. Country-specific market overview - India
- Observation
- Key competitors
2.7.2(A) Country-specific market overview - India by revenue and by volume
- India historical (2015-2017) market revenue (USD Bn)
- India forecasted (2018-2023) market revenue (USD Bn)
- India historical (2015-2017) market volume (Million units)
- India forecasted (2018-2023) market volume (Million units)
2.7.3. Country-specific market overview - Japan
- Observation
- Key competitors
2.7.3(A) Country-specific market overview - Japan-by revenue and by volume
- Japan historical (2015-2017) market revenue (USD Bn)
- Japan forecasted (2018-2023) market revenue (USD Bn)
- Japan historical (2015-2017) market volume (Million units)
- Japan forecasted (2018-2023) market volume (Million units)
2.7.4. Country-specific market overview - South Korea
- Observation
- Key competitors
2.7.3(A) Country-specific market overview - South Korea-by revenue and by volume
- South Korea historical (2015-2017) market revenue (USD Bn)
- South Korea forecasted (2018-2023) market revenue (USD Bn)
- South Korea historical (2015-2017) market volume (Million units)
- South Korea forecasted (2018-2023) market volume (Million units)
Chapter 3: Asia-Pacific major segment overview - by disease indication
3.1. Disease indication: Pneumococcal, Hib - by revenue, by volume, CAGR
- Overview - by disease indication
- Market share (2015, 2018 & 2023): Pneumococcal - Asia-Pacific (USD Bn, Million units)
- Market share (2015, 2018 & 2023): Hib - Asia-Pacific (USD Bn, Million units)
3.2. Disease indication: DTP, Meningococcal - by revenue, by volume, CAGR
- Overview - by disease indication
- Market share (2015, 2018 & 2023): DTP - Asia-Pacific (USD Bn, Million units)
- Market share (2015, 2018 & 2023): Meningococcal - Asia-Pacific (USD Bn, Million units)
Chapter 4: Asia-Pacific major segment overview - by end user
4.1. End-user: Pediatric, Adult - by revenue, by volume, CAGR
- Overview - by end user
- Market share (2015, 2018 & 2023): Paediatric - Asia-Pacific (USD Bn, Million units)
- Market share (2015, 2018 & 2023): Adult - Asia-Pacific (USD Bn, Million units)
Chapter 5: China - by disease indication
5.1. China: disease indication - Pneumococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
5.2. China: disease indication - Haemophilus Influenza type b conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
5.3. China: disease indication - Diphtheria-Tetanus-Pertussis conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
5.4. China: disease indication - Meningococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
Chapter 6: China - by end user
6.1. China: end user - Pediatric & Adult conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Key takeaways
Chapter 7: India - by disease indication
7.1. India: disease indication - Pneumococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
7.2. India: disease indication - Haemophilus Influenza type b conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
7.3. India: disease indication - Diphtheria-Tetanus-Pertussis conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
7.4. India: disease indication - Meningococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
Chapter 8: India - by end user
8.1. India: end user - Pediatric & Adult conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Key takeaways
Chapter 9: Japan - by disease indication
9.1. Japan: disease indication - Pneumococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
9.2. Japan: disease indication - Haemophilus Influenza type b conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
9.3. Japan: disease indication - Diphtheria-Tetanus-Pertussis conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
9.4. Japan: disease indication - Meningococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
Chapter 10: Japan - by end user
10.1. China: end user - Pediatric & Adult conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Key takeaways
Chapter 11: South Korea - by disease indication
11.1. South Korea: disease indication - Pneumococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
11.2. South Korea: disease indication - Haemophilus Influenza type b conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
11.3. South Korea: disease indication - Diphtheria-Tetanus-Pertussis conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
11.4. South Korea: disease indication - Meningococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
Chapter 12: South Korea - by end user
12.1. South Korea: end user - Pediatric & Adult conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Key takeaways
Chapter 13: Competitive landscape
13.1. Company market share
- Top 5 companies
13.2. Company overview - GlaxoSmithKline
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
13.2(A) Executive profile - GlaxoSmithKline
13.3. Company overview - Pfizer Inc.
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
13.3(A) Executive profile - Pfizer Inc.
13.4. Company overview - Merck & Co.
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
13.4(A) Executive profile - Merck & Co.
13.5. Company overview - Novartis
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
13.5(A) Executive profile - Novartis
13.6. Company overview - Sanofi Pasteur
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
13.6(A) Executive profile - Sanofi Pasteur
13.7. Company overview - CSL Limited
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
13.7(A) Executive profile - CSL Limited
13.8. Company overview - Bharat Biotech
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
13.8(A) Executive profile - Bharat Biotech
13.9. Company overview - Biological E. Limited
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
13.9(A) Executive profile - Biological E. Limited
13.10. Company overview - Serum Institute of India
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
13.10(A) Executive profile - Serum Institute of India
Appendix
- List of tables
- Assumptions
- Conclusion
- Research and methodology
- About Netscribes Inc.
Disclaimer: The Table of Contents (ToC) provided above contains the targeted coverage. The coverage is subject to change as we progress with the research
Global Antioxidant Vitamins Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 100
The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
Global Clavulanate Potassium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030.
North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
Global Amoxicillin Sodium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 84
The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030.
North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
Global Melatonin Supplements Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 93
The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
Global Sleeping Pills Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Zinc Oral Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
Global Zinc Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
Global Anti-Infectives Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
